91 related articles for article (PubMed ID: 30232464)
1. Correction: Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.
Maekawa T; Osawa Y; Izumi T; Nagao S; Takano K; Okada Y; Tachi N; Teramoto M; Kawamura T; Horiuchi T; Saga R; Kato S; Yamamura T; Watanabe J; Kobayashi A; Kobayashi S; Sato K; Hashimoto M; Suzu S; Kimura F
Leukemia; 2018 Dec; 32(12):2729-2730. PubMed ID: 30232464
[TBL] [Abstract][Full Text] [Related]
2. Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.
Maekawa T; Osawa Y; Izumi T; Nagao S; Takano K; Okada Y; Tachi N; Teramoto M; Kawamura T; Horiuchi T; Saga R; Kato S; Yamamura T; Watanabe J; Kobayashi A; Kobayashi S; Sato K; Hashimoto M; Suzu S; Kimura F
Leukemia; 2017 Dec; 31(12):2709-2716. PubMed ID: 28386106
[TBL] [Abstract][Full Text] [Related]
3. Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.
Vantaku V; Putluri V; Bader DA; Maity S; Ma J; Arnold JM; Rajapakshe K; Donepudi SR; von Rundstedt FC; Devarakonda V; Dubrulle J; Karanam B; McGuire SE; Stossi F; Jain AK; Coarfa C; Cao Q; Sikora AG; Villanueva H; Kavuri SM; Lotan Y; Sreekumar A; Putluri N
Oncogene; 2020 Oct; 39(40):6387-6392. PubMed ID: 32820250
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations of calreticulin in myeloproliferative neoplasms.
Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
[TBL] [Abstract][Full Text] [Related]
5. Correction to: SPECT/CT imaging of apoptosis in aortic aneurysm with radiolabeled duramycin.
Hu C; Tan H; Lin Q; Abudupataer M; Zhao Y; Li J; Gu J; Cheng D; Wang C; Zhu K; Lai H
Apoptosis; 2019 Oct; 24(9-10):756-757. PubMed ID: 31422488
[TBL] [Abstract][Full Text] [Related]
6. Correction to: Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium.
Zhang J; Song J; Wu D; Wang J; Dong W
Med Oncol; 2019 Mar; 36(4):38. PubMed ID: 30903396
[TBL] [Abstract][Full Text] [Related]
7. Correction to: High‑Mobility Group Box‑1‑Induced Angiogenesis After Indirect Bypass Surgery in a Chronic Cerebral Hypoperfusion Model.
Nishihiro S; Hishikawa T; Hiramatsu M; Kidani N; Takahashi Y; Murai S; Sugiu K; Higaki Y; Yasuhara T; Borlongan CV; Date I
Neuromolecular Med; 2020 Jun; 22(2):332-333. PubMed ID: 32103453
[TBL] [Abstract][Full Text] [Related]
8. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
9. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
Michiels JJ; Berneman Z; Schroyens W; De Raeve H
Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
[TBL] [Abstract][Full Text] [Related]
10. Author Correction: Uplift of the central transantarctic mountains.
Wannamaker P; Hill G; Stodt J; Maris V; Ogawa Y; Selway K; Boren G; Bertrand E; Uhlmann D; Ayling B; Green AM; Feucht D
Nat Commun; 2018 Feb; 9(1):740. PubMed ID: 29453353
[TBL] [Abstract][Full Text] [Related]
11. Publisher Correction: Fgf10 is essential for limb and lung formation.
Sekine K; Ohuchi H; Fujiwara M; Yamasaki M; Yoshizawa T; Sato T; Yagishita N; Matsui D; Koga Y; Itoh N; Kato S
Nat Genet; 2019 May; 51(5):921. PubMed ID: 30948796
[TBL] [Abstract][Full Text] [Related]
12. WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis.
Cottin L; Riou J; Boyer F; Bouvier A; Zannetti A; Blouet A; Truchan-Graczyk M; Jouanneau-Courville R; Beucher A; Ribourtout B; Orvain C; Hunault-Berger M; Blanchet O; Ugo V; Luque Paz D
Blood Cells Mol Dis; 2019 Mar; 75():35-40. PubMed ID: 30612065
[TBL] [Abstract][Full Text] [Related]
13. Author Correction: Culex pipiens crossing type diversity is governed by an amplified and polymorphic operon of Wolbachia.
Bonneau M; Atyame C; Beji M; Justy F; Cohen-Gonsaud M; Sicard M; Weill M
Nat Commun; 2018 Apr; 9(1):1491. PubMed ID: 29643367
[TBL] [Abstract][Full Text] [Related]
14. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
[TBL] [Abstract][Full Text] [Related]
16. The role of the MPL receptor in myeloproliferative disorders.
Kaushansky K
Leukemia; 1998 Sep; 12 Suppl 1():S47-50. PubMed ID: 9777896
[TBL] [Abstract][Full Text] [Related]
17. Correction to "Implementation of Technology-based Patient Engagement Strategies within Practice-Based Research Networks".
J Am Board Fam Med; 2017; 30(4):561. PubMed ID: 28720641
[TBL] [Abstract][Full Text] [Related]
18. MPLW515L mutation in acute megakaryoblastic leukaemia.
Hussein K; Bock O; Theophile K; Schulz-Bischof K; Porwit A; Schlue J; Jonigk D; Kreipe H
Leukemia; 2009 May; 23(5):852-5. PubMed ID: 19194467
[TBL] [Abstract][Full Text] [Related]
19. Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders.
Klippel S; Pahl HL
Pathol Biol (Paris); 2004 Jun; 52(5):267-74. PubMed ID: 15217712
[TBL] [Abstract][Full Text] [Related]
20. Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.
Glembotsky AC; Korin L; Lev PR; Chazarreta CD; Marta RF; Molinas FC; Heller PG
Eur J Haematol; 2010 May; 84(5):398-405. PubMed ID: 20113333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
